XML 102 R47.htm IDEA: XBRL DOCUMENT
v3.25.1

Note H - Stockholders' Equity (Details Textual) - USD ($) |  |  | 12 Months Ended |
--- | --- | --- | --- | ---
Jan. 12, 2024 | Dec. 10, 2023 | Dec. 31, 2024 | Dec. 31, 2023 | Dec. 31, 2022
Accrued Liabilities to Noncontrolling Interests |  |  | $ 0 | $ 214,000 |
Repurchase of Noncontrolling Interest |  |  |  | (214,000) |
Stock Issued During Period Shares, Warrants Exercised (in shares) |  |  | 103,500 |  |
Class of Warrant or Right, Exercised During Period, Exercise Price (in dollars per share) |  |  | $ 0.5 |  |
Proceeds from Warrant Exercises |  |  | $ 51,751 | $ 0 |
Deferred Compensation Arrangement with Individual, Shares Authorized for Issuance (in shares) |  |  | 3,393,017 | 3,098,917 | 2,440,673
Chief Executive Officer, Chief Financial Officer and Employees [Member] |  |  |  |  |
Deferred Compensation Arrangement with Individual, Shares Authorized for Issuance (in shares) |  |  | 2,761,225 | 2,571,292 |
Non-Employees [Member] |  |  |  |  |
Common Stock, Capital Shares Reserved for Future Issuance (in shares) |  |  | 631,792 | 527,625 |
Additional Paid-in Capital [Member] |  |  |  |  |
Repurchase of Noncontrolling Interest |  |  |  | $ (485,119) |
Milestone Medical Inc. [Member] |  |  |  |  |
Business Combination, Consideration Transferred, Equity Interests Issued and Issuable |  | $ 205,000 |  |  |
Accrued Liabilities to Noncontrolling Interests |  |  |  | 214,000 |
Milestone Medical Inc. [Member] | Additional Paid-in Capital [Member] |  |  |  |  |
Repurchase of Noncontrolling Interest |  |  |  | $ 485,000 |
Public Offering [Member] |  |  |  |  |
Stock Issued During Period, Shares, New Issues (in shares) |  | 4,765,000 |  |  |
Shares Issued, Price Per Share (in dollars per share) |  | $ 0.63 |  |  |
Proceeds from Issuance of Common Stock |  | $ 2.6 |  |  |
Over-Allotment Option [Member] |  |  |  |  |
Stock Issued During Period, Shares, New Issues (in shares) | 372,110 | 714,750 |  |  |
Proceeds from Issuance of Common Stock | $ 192,156 |  |  |  |

X
- Definition Accrued liabilities and noncontrolling interest. + References No definition available. + Details
Name: | mlss_AccruedLiabilitiesToNoncontrollingInterests
Namespace Prefix: | mlss_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | instant

X
- Definition Exercise price per share of warrants or rights exercised during period. + References No definition available. + Details
Name: | mlss_ClassOfWarrantOrRightExercisedDuringPeriodExercisePrice
Namespace Prefix: | mlss_
Data Type: | dtr-types:perShareItemType
Balance Type: | na
Period Type: | duration

X
- Definition The repurchase of noncontrolling interest. + References No definition available. + Details
Name: | mlss_RepurchaseOfNoncontrollingInterest
Namespace Prefix: | mlss_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Number of shares issued for warrants exercised. + References No definition available. + Details
Name: | mlss_StockIssuedDuringPeriodSharesWarrantsExercised
Namespace Prefix: | mlss_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | duration

X
- Definition Amount of equity interests of the acquirer, including instruments or interests issued or issuable in consideration for the business combination. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Section 30 -Paragraph 8 -SubTopic 30 -Topic 805 -Publisher FASB -URI https://asc.fasb.org/1943274/2147479637/805-30-30-8 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Section 30 -Paragraph 7 -SubTopic 30 -Topic 805 -Publisher FASB -URI https://asc.fasb.org/1943274/2147479637/805-30-30-7 + Details
Name: | us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Aggregate number of common shares reserved for future issuance. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 210 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02(29)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1 + Details
Name: | us-gaap_CommonStockCapitalSharesReservedForFutureIssuance
Namespace Prefix: | us-gaap_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | instant

X
- Definition The maximum number of shares authorized for issuance under the deferred compensation arrangement as of the balance sheet date. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (a)(3) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 + Details
Name: | us-gaap_DeferredCompensationArrangementWithIndividualSharesAuthorizedForIssuance
Namespace Prefix: | us-gaap_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | instant

X
- Definition The cash inflow from the additional capital contribution to the entity. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Section 45 -Paragraph 14 -Subparagraph (a) -SubTopic 10 -Topic 230 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482740/230-10-45-14 + Details
Name: | us-gaap_ProceedsFromIssuanceOfCommonStock
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition The cash inflow associated with the amount received from holders exercising their stock warrants. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 230 -SubTopic 10 -Name Accounting Standards Codification -Section 45 -Paragraph 14 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482740/230-10-45-14 + Details
Name: | us-gaap_ProceedsFromWarrantExercises
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Per share or per unit amount of equity securities issued. + References No definition available. + Details
Name: | us-gaap_SharesIssuedPricePerShare
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:perShareItemType
Balance Type: | na
Period Type: | instant

X
- Definition Number of new stock issued during the period. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Section 50 -Paragraph 2 -SubTopic 10 -Topic 505 -Publisher FASB -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 210 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02(28)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1 Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 210 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02(29)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 505 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147478448/946-505-50-2 Reference 5: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 220 -Name Accounting Standards Codification -Section S99 -Paragraph 3 -Subparagraph (SX 210.6-09(4)(b)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3 Reference 6: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 3 -Subparagraph (SX 210.6-03(i)(1)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3 Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 505 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.3-04) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1 + Details
Name: | us-gaap_StockIssuedDuringPeriodSharesNewIssues
Namespace Prefix: | us-gaap_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | duration

X
- Details
Name: | srt_TitleOfIndividualAxis=mlss_ChiefExecutiveOfficerChiefFinancialOfficerAndEmployeesMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_TitleOfIndividualAxis=mlss_NonemployeesMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_StatementEquityComponentsAxis=us-gaap_AdditionalPaidInCapitalMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_BusinessAcquisitionAxis=mlss_MilestoneMedicalIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_SubsidiarySaleOfStockAxis=mlss_PublicOfferingMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_SubsidiarySaleOfStockAxis=us-gaap_OverAllotmentOptionMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |